| Cell line name |
INT-MEL-39 |
|---|
| Synonyms |
Me16938; Me1693/8 |
|---|
| Accession |
CVCL_C674 |
|---|
| Resource Identification Initiative |
To cite this cell line use: INT-MEL-39 (RRID:CVCL_C674) |
|---|
| Comments |
Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. |
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
40Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=8459226; DOI=10.1084/jem.177.4.989; PMCID=PMC2190978
Anichini A., Maccalli C., Mortarini R., Salvi S., Mazzocchi A., Squarcina P., Herlyn M., Parmiani G.
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
J. Exp. Med. 177:989-998(1993) DOI=10.1007/0-306-46872-7_16
Anichini A., Mortarini R., Vegetti C., Molla A., Borri A., Parmiani G.
Melanoma: the Milan melanoma cell lines.
(In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.283-292; Kluwer Academic Publishers; New York; USA (1999) DOI=10.13130/grazia-giulia_phd2016-02-18
Grazia G.
Co-targeting of oncogenic and death receptors pathways in human melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic strategy.
Thesis PhD (2015); Universita degli studi di Milano; Milano; Italy |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54897784
|
|---|
| Entry history |
|---|
| Entry creation | 22-Oct-2012 |
|---|
| Last entry update | 10-Apr-2025 |
|---|
| Version number | 12 |
|---|
